The National Institute on Aging (NIA) awarded a $778,551 Project Grant under the Aging Research program (CFDA 93.866) to The RAND Corporation, doing business as RAND Corp, to conduct research on disparities in undiagnosed and misdiagnosed dementia, and the resulting impact on healthcare utilization and costs. The 5-year project aims to: 1) Derive a novel probabilistic Alzheimer's disease and Alzheimer's disease-related dementia (AD/ADRD) classification method using Medicare and Health and Retirement Study data to identify older adults living with undiagnosed or delayed AD/ADRD diagnoses; 2) Estimate the impact of AD/ADRD status and diagnosis on healthcare utilization, costs, and mortality; and 3) Examine disparities in AD/ADRD status and diagnosis, particularly between racial/ethnic groups and rural/urban populations, and the associated cost implications. The research findings are expected to significantly improve estimates of the economic and health impacts of AD/ADRD, especially for minority populations, to inform policymaking and identify potential gains from correcting diagnosis errors and providing needed services.
Generated 3/4/25, 8:39 AM